Neal Shore, MD, FACS (Activity Chair)
  Director, CPI, Carolina Urologic Research Center
  Atlantic Urology Clinics
  Myrtle Beach, South Carolina

 Andrea B. Apolo, MD
 Medical Oncologist 
 Bethesda, Maryland 
 

 Arjun V. Balar, MD
 Director, Genitourinary Medical Oncology Program
 NYU Langone Perlmutter Cancer Center
 New York, New York 
 

In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.

Any person who may contribute to the content of this continuing education activity must disclose relevant relationships (and any known relationships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Relevant relationships include receiving from a commercial interest research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.

Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Planners
Susan H. Gitzinger, PharmD, MPA–has no financial relationships to disclose in relation to this activity. . 
Kirollos S. Hanna, PharmD, BCPS, BCOP–has disclosed that he is a consultant for Seattle Genetics and is a member of the speakers' bureau for Astellas, Bristol-Myers Squibb, and Seattle Genetics. 

Faculty
Neal Shore, MD, FACS–has disclosed that he is a consultant and receives grant/research support from Abbvie, Amgen, AstraZeneca, Bayer, Bristol-Myers Squibb, Color Genomics, Dendreon, Ferring, Genentech, Genomic Health, Genzyme, Innovia, Invitae, Janssen, Merck, Myriad, Nymox, Panacea, Pfizer, Roche, Sanofi, and Tolmar.
Arjun V. Balar, MD–has disclosed that he is a consultant for AstraZeneca/Medimmune, Genentech, Immunomedics, Incyte, Janssen, Merck, Nektar, Pfizer, and Seattle Genetics. He receives grant/research support from AstraZeneca/Medimmune (institution), Genentech (institution), Immunomedics (institution), Merck (institution), Nektar, and Seattle Genetics (institution). He is a member of the Speakers' Bureau for AstraZeneca/Medimmune, Genentech, and Merck. He has equity and is a Scientific Advisory Board Member for EpiVax Oncology. He is also on the Steering/Scientific Advisory Committee for Merck and Nektar.
Andrea B. Apolo, MD–has no financial relationships to disclose in relation to this activity. 

Content Reviewers
Bishoy Morris Faltas, MD–has no financial relationships to disclose in relation to this activity. 
Sami Larson, PharmD–has no financial relationships to disclose in relation to this activity. 
Caroline Pratz, CRNP–has no financial relationships to disclose in relation to this activity.